TOP WATCHED SPORT Orders DNA Swabs — Why Now?

DNA double helix with glowing particles — Photo: Billion Photos / Shutterstock

When the world’s top woman in tennis backs DNA testing to keep men out of her sport, it signals how far major institutions are now willing to go to police sex in the name of “fairness.”

Story Snapshot

The Women’s Tennis Association now requires a one-time genetic sex test for every player on the women’s tour.
World No. 1 Aryna Sabalenka strongly supports the rule, saying it is needed to keep competition fair.
Critics warn the policy is invasive, risks stigma, and revives a long, troubled history of sex testing in women’s sports.
The rule applies even though there are no known transgender women currently competing on the tour.

Top Player Backs New Genetic Rule in Women’s Tennis

The Women’s Tennis Association has changed its eligibility rules for the women’s tour by adding a one-time genetic sex test for every player. The test looks for the SRY gene, a piece of DNA linked with typical male development. Aryna Sabalenka, the current world number one, publicly backed the rule at a press conference before the Toronto tournament in August 2026. She said men are “way stronger than women” and insisted the test is needed to keep matches fair.

Sabalenka told reporters she is “happy” to be tested and wants all players treated the same under the new rule. She tied fairness directly to biological sex, saying it would not be fair for women to compete against “biological men.” Her comments were carried by outlets across Europe and North America, turning a technical rule change into a global culture story. Supporters see her stance as proof that many top women athletes feel their category is under real threat.

What the WTA Policy Actually Does

The Women’s Tennis Association says the updated policy is meant “to preserve the integrity of women’s professional tennis and maintain fair competition conditions for all players.” Every player on the women’s tour must give a cheek swab or blood sample once, so laboratories can check for the SRY gene. Those who test “negative” under the rule can keep playing on the women’s circuit, including the four Grand Slam events. The association says the process is confidential and includes data privacy safeguards.

Reports say the rule can carry real penalties for those who refuse or are found ineligible. A player document quoted in coverage explains that refusing the test may lead to disciplinary action and removal from events. Ineligibility can also become public or the subject of speculation, despite promised privacy protections. The Women’s Tennis Association presents the policy as based on biological sex instead of gender identity, stressing that it does not aim to insult or disrespect anyone. However, that framing does not ease all concerns.

Players and Advocates Raise Privacy and Dignity Concerns

Player groups and human rights advocates argue that mandatory genetic testing is invasive and may violate bodily autonomy. They warn that taking DNA samples from every woman on tour, even when there is no specific concern, crosses a line from fair rules into deep personal monitoring. Critics say the policy risks labeling some women as “not female enough,” echoing past harms in sports where officials questioned women’s bodies and identities. So far, no public evidence shows test results being leaked or misused under this new rule.

🔴 WTA mandates genetic sex test for all players; Sabalenka backs policy

In July 2026, the Women's Tennis Association introduced mandatory one-time genetic testing for all players, screening for the SRY gene via cheek swab or blood test. Players who refuse face disciplinary… pic.twitter.com/V8opcFULWk

— NewsTongue (@NewsTongueX) August 4, 2026

Opponents also point to a basic fact: reports say there are no known transgender women currently playing on the Women’s Tennis Association tour. They argue that testing everyone to solve a problem that does not yet exist feels more like political theater than targeted regulation. For many fans, this fits a wider pattern where big organizations demand more private data while ordinary people feel they have less control. It feeds long-running fears on both left and right that powerful elites use rules as tools, not as protections.

A Long History of Sex Testing in Women’s Sports

This fight in tennis continues a long cycle in global sports, where leaders claim they are protecting women by checking who counts as “female.” The International Olympic Committee once required sex verification for every woman athlete from 1968 to 1998. Track and field’s global body used blanket testing and even crude physical exams in the 1960s before backing away under heavy criticism. That history shows how promises of fairness can slide into large-scale policing of women’s bodies.

Recent academic work warns that bringing back mandatory genetic sex testing repeats old mistakes. Scholars note that earlier rules often hurt women with rare medical conditions or differences in sex development, even when they had grown up and trained as women. Human Rights Watch has documented how such testing can push women out of sport altogether, especially those from poorer countries who lack legal support. The new Women’s Tennis Association policy fits this pattern: a broad rule built to stop a few possible cases, yet applied to every woman on tour.

Why This Matters Beyond Tennis

For conservatives who worry that “woke” policies have blurred basic sex differences, Sabalenka’s support looks like a long-awaited pushback inside elite sport. For liberals who fear discrimination and abuse of power, forcing every woman to hand over DNA to a private contractor looks like one more example of institutions valuing control over human dignity. Both sides can see the Women’s Tennis Association rule as another sign that powerful bodies answer to themselves first, and to players and fans only later.

These concerns echo broader anger at government and corporate elites in the United States today. Many Americans see a pattern: leaders say they act for fairness or safety, then introduce systems that collect more data, add more rules, and leave regular people with less say. The fight over genetic sex testing in tennis is not just about sport. It is a window into how major institutions choose winners and losers, and how hard it is for ordinary women to push back once those choices are locked into policy.